US · Healthcare

Passage Bio Inc (PASG)

Biotechnology

Passage Bio Inc (PASG) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for PASG

P/E ratio

18.00

Passage Bio Inc (PASG) — FAQ

What is PASG's P/E ratio?

The price-to-earnings (P/E) ratio for Passage Bio Inc (PASG) is 18.00 (data as of 2026-03-24).

Does Passage Bio Inc pay a dividend?

Dividend yield is not available in the current snapshot for Passage Bio Inc (PASG). Check the MyAverix Finance app for the latest dividend data.

What sector is Passage Bio Inc in?

Passage Bio Inc (PASG) is classified in the Healthcare sector (Biotechnology industry).

What exchange is PASG listed on?

PASG is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)